Status:
RECRUITING
Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases
Lead Sponsor:
Institut Investigacio Sanitaria Pere Virgili
Conditions:
Prehabilitation
Neoadjuvant Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Liver resection is the only curative treatment for patients with colorectal liver metastases (CRLM). Most patients undergo chemotherapy (CT) before liver surgery. CT objectively decreases patient func...
Detailed Description
The primary aim of the study is to evaluate the effectiveness of a multimodal prehabilitation program (MPP) in CRLM patients, which will be implemented right through the period of preoperative CT and ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Written informed consent obtained from subject to participate in the study.
Exclusion
- Age \<18 years
- ASA health class status IV-V
- Mental conditions or disabling orthopedic and neuromuscular disease that prevent physical exercise or may compromise adherence to the program
- Medical contraindication to perform exercise
- Inability to obtain informed consent
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04520737
Start Date
February 1 2021
End Date
December 31 2026
Last Update
July 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari de Tarragona Joan XXIII
Tarragona, Spain, 43005